180 related articles for article (PubMed ID: 32598892)
1. Optimizing Nonsurgical Treatments of Overactive Bladder in the United States.
Brucker BM; Lee RK; Newman DK
Urology; 2020 Nov; 145():52-59. PubMed ID: 32598892
[TBL] [Abstract][Full Text] [Related]
2. Understanding clinic options for overactive bladder.
Bartley JM; Blum ES; Sirls LT; Peters KM
Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
[TBL] [Abstract][Full Text] [Related]
3. An overview of treatment of overactive bladder syndrome in women.
Allahdin S; Oo N
J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
[TBL] [Abstract][Full Text] [Related]
4. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
Ellsworth P
Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Bywater M; Kessler TM
Praxis (Bern 1994); 2017; 106(21):1175-1181. PubMed ID: 29041854
[No Abstract] [Full Text] [Related]
6. Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies.
Ginsberg DA; Schneider LK; Watanabe TK
Arch Phys Med Rehabil; 2015 Sep; 96(9 Suppl):S341-57.e1. PubMed ID: 26318392
[TBL] [Abstract][Full Text] [Related]
7. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of female overactive bladder syndrome and treatment-related effects.
Hsiao SM; Lin HH
J Formos Med Assoc; 2018 Oct; 117(10):871-878. PubMed ID: 29398096
[TBL] [Abstract][Full Text] [Related]
9. Re: Pathophysiology of Idiopathic Overactive Bladder and the Success of Treatment: A Systematic Review from ICI-RS 2013.
Wein AJ
J Urol; 2015 Aug; 194(2):474. PubMed ID: 26195388
[No Abstract] [Full Text] [Related]
10. New therapies in the treatment of overactive bladder.
Yeo EK; Hashim H; Abrams P
Expert Opin Emerg Drugs; 2013 Sep; 18(3):319-37. PubMed ID: 23885696
[TBL] [Abstract][Full Text] [Related]
11. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
12. Management of refractory OAB in the non-neurogenic patient.
Wadie BS
Curr Urol Rep; 2014 Sep; 15(9):438. PubMed ID: 25015301
[TBL] [Abstract][Full Text] [Related]
13. Overactive bladder - 18 years - Part II.
Truzzi JC; Gomes CM; Bezerra CA; Plata IM; Campos J; Garrido GL; Almeida FG; Averbeck MA; Fornari A; Salazar A; Dell'Oro A; Cintra C; Sacomani CA; Tapia JP; Brambila E; Longo EM; Rocha FT; Coutinho F; Favre G; Garcia JA; Castano J; Reyes M; Leyton RE; Ferreira RS; Duran S; Lopez V; Reges R
Int Braz J Urol; 2016; 42(2):199-214. PubMed ID: 27176185
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy of overactive bladder--what is coming next?
Andersson KE
Korean J Urol; 2015 Oct; 56(10):673-9. PubMed ID: 26495067
[TBL] [Abstract][Full Text] [Related]
15. New evidence in the treatment of overactive bladder.
Brown ET; Martin L; Dmochowski RR
Curr Opin Obstet Gynecol; 2015 Oct; 27(5):366-72. PubMed ID: 26308197
[TBL] [Abstract][Full Text] [Related]
16. [Overactive bladder syndrome--a public health challenge].
Veit-Rubin N; Meyer S; Achtari C
Rev Med Suisse; 2015 Oct; 11(492):2016-21. PubMed ID: 26672181
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of overactive bladder.
American Urogynecological Society’s Guidelines Development Committee
Female Pelvic Med Reconstr Surg; 2013; 19(6):316. PubMed ID: 24165442
[No Abstract] [Full Text] [Related]
18. [Neuromodulation as a treatment for overactive bladder syndrome].
Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
[TBL] [Abstract][Full Text] [Related]
19. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis.
Balzarro M; Rubilotta E; Mancini V; Trabacchin N; Oppezzi L; Li Marzi V; Fusco F; Serati M
Sex Med Rev; 2019 Oct; 7(4):565-574. PubMed ID: 31326358
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of novel therapies for overactive bladder.
Mayr CA; Shepherd JP
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):527-35. PubMed ID: 24809616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
